These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 39309428

  • 1. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m6A-YTHDF1-dependent manner.
    Zhang R, Chen P, Wang Y, Zeng Z, Yang H, Li M, Liu X, Yu W, Hou P.
    Int J Biol Sci; 2024; 20(12):4750-4766. PubMed ID: 39309428
    [Abstract] [Full Text] [Related]

  • 2. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 3. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X, Wang Z, Lu W, Miao L, Zhao Y.
    BMC Pulm Med; 2022 Aug 25; 22(1):324. PubMed ID: 36008805
    [Abstract] [Full Text] [Related]

  • 4. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W, Xiao G, Xie G, Chen Z, Xu X, Zeng J, Xie J.
    Thorac Cancer; 2024 Sep 25; 15(26):1871-1881. PubMed ID: 39090761
    [Abstract] [Full Text] [Related]

  • 5. N6-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing.
    Wang A, Zeng Y, Zhang W, Zhao J, Gao L, Li J, Zhu J, Liu Z, Huang JA.
    Cell Mol Biol Lett; 2024 Aug 02; 29(1):106. PubMed ID: 39095708
    [Abstract] [Full Text] [Related]

  • 6. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification.
    Fan Y, Yu Y.
    Hum Cell; 2024 Jul 02; 37(4):1120-1131. PubMed ID: 38625505
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
    Sun H, Zhou X, Bao Y, Xiong G, Cui Y, Zhou H.
    Open Biol; 2019 Jul 26; 9(7):180227. PubMed ID: 31337279
    [Abstract] [Full Text] [Related]

  • 9. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y, Liu S, Zhao T, Dang C.
    Oncol Rep; 2021 Aug 26; 46(2):. PubMed ID: 34132367
    [Abstract] [Full Text] [Related]

  • 10. The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene.
    Liu S, Li Q, Li G, Zhang Q, Zhuo L, Han X, Zhang M, Chen X, Pan T, Yan L, Jin T, Wang J, Lv Q, Sui X, Xie T.
    Cell Death Dis; 2020 Nov 11; 11(11):969. PubMed ID: 33177491
    [Abstract] [Full Text] [Related]

  • 11. Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.
    Chen Y, Zhou H, Yang S, Su D.
    Cell Biochem Funct; 2021 Mar 11; 39(2):277-286. PubMed ID: 32815556
    [Abstract] [Full Text] [Related]

  • 12. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C, Ren Q, Deng J, Wang S, Ren L.
    Biomed J; 2024 Aug 11; 47(4):100664. PubMed ID: 37774794
    [Abstract] [Full Text] [Related]

  • 13. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
    Qian CY, Zheng Y, Wang Y, Chen J, Liu JY, Zhou HH, Yin JY, Liu ZQ.
    Chin J Cancer; 2016 Sep 02; 35(1):85. PubMed ID: 27590272
    [Abstract] [Full Text] [Related]

  • 14. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.
    Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, Zhu W, Zhang J.
    J Exp Clin Cancer Res; 2023 Mar 17; 42(1):65. PubMed ID: 36932427
    [Abstract] [Full Text] [Related]

  • 15. XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer.
    Wang J, Fan P, Shen P, Fan C, Zhao P, Yao Shen, Dong K, Ling R, Chen S, Zhang J.
    Cancer Lett; 2024 Aug 01; 596():216846. PubMed ID: 38582397
    [Abstract] [Full Text] [Related]

  • 16. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 17. The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity.
    Xuan YF, Lu S, Ou YJ, Bao XB, Huan XJ, Song SS, Miao ZH, Wang YQ.
    Biochem Biophys Res Commun; 2024 Jul 05; 716():150011. PubMed ID: 38704890
    [Abstract] [Full Text] [Related]

  • 18. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L, Xu J, Zhao F, Dai X, Tao J, Pan J, Shi A, Shen Z, Su C, Zhang Y.
    Eur J Pharmacol; 2021 May 15; 899():174054. PubMed ID: 33771522
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin.
    Gong S, Wang S, Shao M.
    J Mol Med (Berl); 2022 Dec 15; 100(12):1771-1785. PubMed ID: 36352154
    [Abstract] [Full Text] [Related]

  • 20. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D, Fu Z, Dong C, Song Y.
    Bioengineered; 2022 Apr 15; 13(4):10493-10503. PubMed ID: 35441574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.